Every day, AHA staff take to Capitol Hill to tell the hospital story, working to educate Congress on key issues and the field’s concerns. We also advocate with federal regulators, provide expert testimony, and highlight the impact proposed changes could have and suggest alternative solutions. Below are the most recent statements the AHA has submitted for the record for congressional hearings or agency panels.


Jul 26, 2018
Statement of the American Hospital Association before the Subcommittee on Health of the Committee on Energy and Commerce of the U.S. House of Representatives providing input on the implementation of the Merit-based Incentive Payment System, which is part of the Quality Payment Program mandated by the Medicare Access and CHIP Reauthorization Act of 2015.
Jul 18, 2018
AHA statement before the House Committee on Ways and Means, Subcommittee on Health regarding "Modernizing Stark Law to Ensure the Successful Transition from Volume to Value in the Medicare Program."
Jul 18, 2018
AHA testimony before the House Committee on Oversight and Government Reform regarding cybersecurity threats facing hospitals, health systems and the health care field. 
Jul 17, 2018
AHA statement before the Senate Committee on Health, Education, Labor and Pensions on Reducing Health Care Costs: Eliminating Excess Health Care Spending and Improving Quality and Value for Patients.”
Jul 17, 2018
AHA statement before the House Energy and Commerce Subcommittee on Communications and Technology: Realizing the Benefits of Rural Broadband: Challenges and Solutions.
Jul 10, 2018
On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, including more than 1,900 hospitals that participate in the 340B drug savings program, and our cl
Jun 27, 2018
AHA statement before the Senate Committee on Health, Education, Labor and Pensions: Hearing on How to Reduce Health Care Costs: Understanding the Cost of Health Care in America”
Jun 26, 2018
AHA statement before the Senate Finance Committee on Prescription Drug Affordability and Innovation: Addressing Challenges in Today’s Market.
Jun 19, 2018
AHA Statement before the Senate Committee on Health, Education, Labor and Pensions regarding “Effective Administration of the 340B Drug Pricing Program.”
Jun 6, 2018
AHA Statement to the Committee on Ways and Means for “Hearing on Lowering Costs and Expanding Access to Health Care through Consumer-Directed Health Plans.”